Skip to content
Screener

Lexaria Bioscience LEXX Q2 2026 earnings

Reported July 13, 2026 · Before market open

EPS-$0.08Miss by $0.02
Revenue estimate$50.0K
EPS estimate-$0.06

Next report

Oct 28, 2026 (in 2 months)
Revenue estimate$50.0K
EPS estimate-$0.90

FAQ

When did Lexaria Bioscience report Q2 2026 earnings?
Lexaria Bioscience (LEXX) reported Q2 2026 earnings on July 13, 2026 before market open.
What were Lexaria Bioscience's Q2 2026 revenue and EPS?
Lexaria Bioscience reported eps of $-0.08 for Q2 2026.
Did Lexaria Bioscience beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.06 by $0.02.
How did Lexaria Bioscience's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 61.9% from $-0.21.
Where can I find Lexaria Bioscience's Q2 2026 SEC filings?
You can read the 10-Q periodic report (0001640334-26-001166) directly on SEC EDGAR. The filing index links above go to sec.gov.